Advertisement
Screener

MERRIMACK PHARMACEUTICALS INC Finite-Lived Intangible Asset, Expected Amortization, Year Five

MERRIMACK PHARMACEUTICALS INC Finite-Lived Intangible Asset, Expected Amortization, Year Five

MERRIMACK PHARMACEUTICALS INC had Finite-Lived Intangible Asset, Expected Amortization, Year Five of $258.00 thousand as of 2016-12-31, per its 10-K filed 2017-03-01.

Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive · last filed 2017-03-01

  • 2016-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $258.00K.
  • 2015-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $258.00K.
  • 2014-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $245.00K.
  • 2013-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $320.00K.
Period endFinite-Lived Intangible Asset, Expected Amortization, Year Five
2016-12-31$258.00K
10-K · filed 2017-03-01
2015-12-31$258.00K
10-K · filed 2016-02-26
2014-12-31$245.00K
10-K · filed 2015-02-27
2013-12-31$320.00K
10-K · filed 2014-03-04
2012-12-31$320.00K
10-K · filed 2013-03-20